A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice

NCT05200221 · clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Shanghai Zhongshan Hospital